- Home
- OST vs OGEN Comparison
OST vs OGEN Comparison
Compare OST & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- OGEN
- Stock Information
- Founded
- OST 2010
- OGEN 1996
- Country
- OST China
- OGEN United States
- Employees
- OST N/A
- OGEN N/A
- Industry
- OST Industrial Machinery/Components
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- OGEN Health Care
- Exchange
- OST Nasdaq
- OGEN Nasdaq
- Market Cap
- OST 4.3M
- OGEN 3.9M
- IPO Year
- OST 2022
- OGEN N/A
- Fundamental
- Price
- OST $2.62
- OGEN $0.29
- Analyst Decision
- OST
- OGEN
- Analyst Count
- OST 0
- OGEN 0
- Target Price
- OST N/A
- OGEN N/A
- AVG Volume (30 Days)
- OST 1.1M
- OGEN 14.3M
- Earning Date
- OST 01-27-2025
- OGEN 03-28-2025
- Dividend Yield
- OST N/A
- OGEN N/A
- EPS Growth
- OST N/A
- OGEN N/A
- EPS
- OST N/A
- OGEN N/A
- Revenue
- OST $32,463,213.00
- OGEN N/A
- Revenue This Year
- OST N/A
- OGEN N/A
- Revenue Next Year
- OST N/A
- OGEN N/A
- P/E Ratio
- OST N/A
- OGEN N/A
- Revenue Growth
- OST N/A
- OGEN N/A
- 52 Week Low
- OST $1.60
- OGEN $0.25
- 52 Week High
- OST $6.10
- OGEN $3.84
- Technical
- Relative Strength Index (RSI)
- OST 51.97
- OGEN 46.16
- Support Level
- OST $2.57
- OGEN $0.28
- Resistance Level
- OST $2.77
- OGEN $0.31
- Average True Range (ATR)
- OST 0.20
- OGEN 0.05
- MACD
- OST -0.02
- OGEN 0.00
- Stochastic Oscillator
- OST 20.69
- OGEN 9.39
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.